FDA Approves High Blood Pressure Medication Studied in PMG Network!
The FDA has approved Edarbyclor (azilsartan medoxomil and chlorthalidone) for the treatment of high blood pressure in adults. Congratulations to all of the participants that contributed to the development of a new high blood pressure combination medication through their participation in Takeda clinical trials with PMG! Thanks to all of the PMG sites that worked so hard on the Edarbyclor projects as well! To learn more about Edarbyclor, please click here.